Literature DB >> 22310933

Memory T cells in the chronic inflammatory microenvironment of nasal polyposis are hyporesponsive to signaling through the T cell receptor.

Heather K Lehman1, Michelle R Simpson-Abelson, Thomas F Conway, Raymond J Kelleher, Joel M Bernstein, Richard B Bankert.   

Abstract

A majority of T cells from chronic inflammatory tissues derived from patients with nasal polyposis were found to express an effector memory phenotype. We report here that these memory T cells failed to activate NF-κB in response to TCR stimulation but responded normally when the proximal TCR signaling molecules were bypassed with PMA and ionomycin. The dysfunction of these cells was associated with a decrease in the phosphorylation of several TCR proximal signaling molecules including ZAP70, Lck and SLP-76. In addition to the disruption in the TCR signaling pathway, the nasal polyp-associated T cells were shown to have a defect in their ability to translocate LAMP-1 to the cell surface. The results presented here establish that the phenotype and anergy of the T cells in the nasal polyp are similar to those which is seen in memory T cells derived from human tumors and other sites of chronic inflammation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22310933      PMCID: PMC3346897          DOI: 10.1007/s10162-012-0313-8

Source DB:  PubMed          Journal:  J Assoc Res Otolaryngol        ISSN: 1438-7573


  43 in total

1.  Differential loss of T cell signaling molecules in metastatic melanoma patients' T lymphocyte subsets expressing distinct TCR variable regions.

Authors:  C Maccalli; P Pisarra; C Vegetti; M Sensi; G Parmiani; A Anichini
Journal:  J Immunol       Date:  1999-12-15       Impact factor: 5.422

2.  HLA patterns in patients with nasal polyposis.

Authors:  W Luxenberger; U Posch; A Berghold; T Hofmann; D Lang-Loidolt
Journal:  Eur Arch Otorhinolaryngol       Date:  2000       Impact factor: 2.503

Review 3.  T-cell activation through the antigen receptor. Part 2: role of signaling cascades in T-cell differentiation, anergy, immune senescence, and development of immunotherapy.

Authors:  Andre E Nel; Ndaisha Slaughter
Journal:  J Allergy Clin Immunol       Date:  2002-06       Impact factor: 10.793

4.  Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation.

Authors:  Michael R Betts; Jason M Brenchley; David A Price; Stephen C De Rosa; Daniel C Douek; Mario Roederer; Richard A Koup
Journal:  J Immunol Methods       Date:  2003-10-01       Impact factor: 2.303

5.  Inhibition of human tumor-infiltrating lymphocyte effector functions by the homophilic carcinoembryonic cell adhesion molecule 1 interactions.

Authors:  Gal Markel; Rachel Seidman; Noam Stern; Tali Cohen-Sinai; Orit Izhaki; Gil Katz; Michal Besser; Avraham J Treves; Richard S Blumberg; Ron Loewenthal; Ofer Mandelboim; Arie Orenstein; Jacob Schachter
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

Review 6.  Immunopathogenesis and immunotherapy in AIDS virus infections.

Authors:  Norman L Letvin; Bruce D Walker
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

7.  CD4+CD25+ and CD4+CD25- T cells act respectively as inducer and effector T suppressor cells in superantigen-induced tolerance.

Authors:  Pascal Feunou; Lionel Poulin; Claude Habran; Alain Le Moine; Michel Goldman; Michel Y Braun
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

8.  Regulation of nuclear translocation of nuclear factor-kappaB relA: evidence for complex dynamics at the single-cell level.

Authors:  Kenneth Schooley; Ping Zhu; Steven K Dower; Eva E Qwarnström
Journal:  Biochem J       Date:  2003-01-15       Impact factor: 3.857

9.  Transcriptional mechanisms underlying lymphocyte tolerance.

Authors:  Fernando Macián; Francisco García-Cózar; Sin-Hyeog Im; Heidi F Horton; Michael C Byrne; Anjana Rao
Journal:  Cell       Date:  2002-06-14       Impact factor: 41.582

10.  Circulating cytotoxic CD8(+) CD28(-) T cells in ankylosing spondylitis.

Authors:  Michael Schirmer; Christian Goldberger; Reinhard Würzner; Christina Duftner; Karl-P Pfeiffer; Johannes Clausen; Günther Neumayr; Albrecht Falkenbach
Journal:  Arthritis Res       Date:  2001-10-16
View more
  3 in total

1.  Human ovarian tumor ascites fluids rapidly and reversibly inhibit T cell receptor-induced NF-κB and NFAT signaling in tumor-associated T cells.

Authors:  Michelle R Simpson-Abelson; Jenni L Loyall; Heather K Lehman; Jennifer L Barnas; Hans Minderman; Kieran L O'Loughlin; Paul K Wallace; Thaddeus C George; Peng Peng; Raymond J Kelleher; Kunle Odunsi; Richard B Bankert
Journal:  Cancer Immun       Date:  2013-07-15

2.  Exosomes Represent an Immune Suppressive T Cell Checkpoint in Human Chronic Inflammatory Microenvironments.

Authors:  Gautam N Shenoy; Maulasri Bhatta; Jenni L Loyall; Raymond J Kelleher; Joel M Bernstein; Richard B Bankert
Journal:  Immunol Invest       Date:  2020-04-17       Impact factor: 3.657

Review 3.  Activated T-effector seeds: cultivating atherosclerotic plaque through alternative activation.

Authors:  Maria M Xu; Patrick A Murphy; Anthony T Vella
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-03-29       Impact factor: 5.125

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.